Amphetamine potency varies with dopamine uptake rate across striatal subregions

Journal of Neurochemistry

Volumn 131, Issue 3, 2014, Pages 348-355

  Siciliano, Cody A ^a   Calipari, Erin S ^b   Jones, Sara R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

caudate; dopamine transporter; mouse; nucleus accumbens; releaser; voltammetry

Indexed keywords

AMPHETAMINE; DOPAMINE; DOPAMINE TRANSPORTER; DOPAMINE UPTAKE INHIBITOR;

ADDICTION; ANIMAL BEHAVIOR; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; BEHAVIORAL SCIENCE; BRAIN FUNCTION; BRAIN LEVEL; BRAIN REGION; BRAIN SLICE; CAUDATE NUCLEUS; CONTROLLED STUDY; CYCLIC POTENTIOMETRY; DOPAMINE RELEASE; DOPAMINE UPTAKE; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUTAMEN; STRIATE CORTEX; ANIMAL; C57BL MOUSE; DRUG EFFECTS; EXOCYTOSIS; KINETICS; METABOLISM; NEOSTRIATUM;

AMPHETAMINE; ANIMALS; CAUDATE NUCLEUS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; EXOCYTOSIS; KINETICS; MALE; MICE; MICE, INBRED C57BL; NEOSTRIATUM; NUCLEUS ACCUMBENS;

EID: 84922230760     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12808     Document Type: Article

References (48)

1. Batchelor M., and, Schenk J. O., (1998) Protein kinase A activity may kinetically upregulate the striatal transporter for dopamine. J. Neurosci. 18, 10304-10309.
2. Beckstead R. M., Domesick V. B., and, Nauta W. J., (1979) Efferent connections of the substantia nigra and ventral tegmental area in the rat. Brain Res. 175, 191-217.
3. Blanchard V., Raisman-Vozari R., Vyas S., Michel P. P., Javoy-Agid F., Uhl G., and, Agid Y., (1994) Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalon. Brain Res. Mol. Brain Res. 22, 29-38.
4. Calipari E. S., Huggins K. N., Mathews T. A., and, Jones S. R., (2012) Conserved dorsal-ventral gradient of dopamine release and uptake rate in mice, rats and rhesus macaques. Neurochem. Int. 61, 986-991.
5. Calipari E. S., Ferris M. J., Salahpour A., Caron M. G., and, Jones S. R., (2013) Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression. Nat. Commun. 4, 2720.
6. Carroll M. E., and, Lac S. T., (1997) Acquisition of i.v. amphetamine and cocaine self-administration in rats as a function of dose. Psychopharmacology 129, 206-214.
7. Comer S. D., Mogali S., Saccone P. A., et al,. (2013) Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers. Neuropsychopharmacology 38, 2427-2438.
8. Coulter C. L., Happe H. K., and, Murrin L. C., (1996) Postnatal development of the dopamine transporter: a quantitative autoradiographic study. Brain Res. Dev. Brain Res. 92, 172-181.
9. Cragg S. J., Hille C. J., and, Greenfield S. A., (2000) Dopamine release and uptake dynamics within nonhuman primate striatum in vitro. J. Neurosci. 20, 8209-8217.
10. Crombag H. S., Ferrario C. R., and, Robinson T. E., (2008) The rate of intravenous cocaine or amphetamine delivery does not influence drug-taking and drug-seeking behavior in rats. Pharmacol. Biochem. Behav. 90, 797-804.
11. Daberkow D. P., Brown H. D., Bunner K. D., Kraniotis S. A., Doellman M. A., Ragozzino M. E., Garris P. A., and, Roitman M. F., (2013) Amphetamine paradoxically augments exocytotic dopamine release and phasic dopamine signals. J. Neurosci. 33, 452-463.
12. Di Chiara G., and, Imperato A., (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl Acad. Sci. USA 85, 5274-5278.
13. Drevets W. C., Gautier C., Price J. C., Kupfer D. J., Kinahan P. E., Grace A. A., Price J. L., and, Mathis C. A., (2001) Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol. Psychiatry 49, 81-96.
14. Everitt B. J., and, Robbins T. W., (2013) From the ventral to the dorsal striatum: devolving views of their roles in drug addiction. Neurosci. Biobehav. Rev. 37 (9 Pt A): 1946-1954.
15. Ferris M. J., Calipari E. S., Yorgason J. T., and, Jones S. R., (2013) Examining the complex regulation and drug-induced plasticity of dopamine release and uptake using voltammetry in brain slices. ACS Chem. Neurosci. 4, 693-703.
16. Fischman M. W., Schuster C. R., Resnekov L., Shick J. F., Krasnegor N. A., Fennell W., and, Freedman D. X., (1976) Cardiovascular and subjective effects of intravenous cocaine administration in humans. Arch. Gen. Psychiatry 133, 983-989.
17. Fleckenstein A. E., Volz T. J., Riddle E. L., Gibb J. W., and, Hanson G. R., (2007) New insights into the mechanism of action of amphetamines. Annu. Rev. Pharmacol. Toxicol. 47, 681-698.
18. Gabriele A., and, See R. E., (2011) Lesions and reversible inactivation of the dorsolateral caudate-putamen impair cocaine-primed reinstatement to cocaine-seeking in rats. Brain Res. 1417, 27-35.
19. Hernandez L., Lee F., and, Hoebel B. G., (1987) Simultaneous microdialysis and amphetamine infusion in the nucleus accumbens and striatum of freely moving rats: increase in extracellular dopamine and serotonin. Brain Res. Bull. 19, 623-628.
20. Hoexter M. Q., Fadel G., Felício A. C., et al,. (2012) Higher striatal dopamine transporter density in PTSD: an in vivo SPECT study with [(99 m)Tc]TRODAT-1. Psychopharmacology 224, 337-345.
21. Ito R., Dalley J. W., Robbins T. W., and, Everitt B. J., (2002) Dopamine release in the dorsal striatum during cocaine-seeking behavior under the control of a drug-associated cue. J. Neurosci. 22, 6247-6253.
22. John C. E., and, Jones S. R., (2007) Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices. Neuropharmacology 52, 1596-1605.
23. Jones S. R., Garris P. A., and, Wightman R. M., (1995) Different effects of cocaine and nomifensine on dopamine uptake in the caudate-putamen and nucleus accumbens. J. Pharmacol. Exp. Ther. 274, 396-403.
24. Jones S. R., Gainetdinov R. R., Wightman R. M., and, Caron M. G., (1998) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J. Neurosci. 18, 1979-1986.
25. Jones S. R., Joseph J. D., Barak L. S., Caron M. G., and, Wightman R. M., (1999) Dopamine neuronal transport kinetics and effects of amphetamine. J. Neurochem. 73, 2406-2414.
26. Kuczenski R., and, Segal D. S., (1992) Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine. J. Pharmacol. Exp. Ther. 262, 1085-1094.
27. Kuczenski R., Segal D. S., and, Aizenstein M. L., (1991) Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics. J. Neurosci. 11, 2703-2712.
28. Madras B. K., Miller G. M., and, Fischman A. J., (2005) The dopamine transporter and attention-deficit/hyperactivity disorder. Biol. Psychiatry 57, 1397-1409.
29. Meiergerd S. M., Patterson T. A., and, Schenk J. O., (1993) D2 receptors may modulate the function of the striatal transporter for dopamine: kinetic evidence from studies in vitro and in vivo. J. Neurochem. 61, 764-767.
30. Pehek E. A., Schechter M. D., and, Yamamoto B. K., (1990) Effects of cathinone and amphetamine on the neurochemistry of dopamine in vivo. Neuropharmacology 29, 1171-1176.
31. Ramsson E. S., Covey D. P., Daberkow D. P., Litherland M. T., Juliano S. A., and, Garris P. A., (2011a) Amphetamine augments action potential-dependent dopaminergic signaling in the striatum in vivo. J. Neurochem. 117, 937-948.
32. Ramsson E. S., Howard C. D., Covey D. P., and, Garris P. A., (2011b) High doses of amphetamine augment, rather than disrupt, exocytotic dopamine release in the dorsal and ventral striatum of the anesthetized rat. J. Neurochem. 119, 1162-1172.
33. Richardson N. R., and, Roberts D. C., (1996) Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J. Neurosci. Methods 66, 1-11.
34. Roberts D. C. S., Koob G. F., Klonoff P., and, Fibiger H. C., (1980) Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol. Biochem. Behav. 12, 781-787.
35. Robinson E. T., and, Camp D. M., (1990) Does amphetamine preferentially increase the extracellular concentration of dopamine in the mesolimbic system of freely moving rats? Neuropsychopharmacology 3, 163-173.
36. Salahpour A., Ramsey A. J., Medvedev I. O., et al,. (2008) Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter. Proc. Natl Acad. Sci. 105, 4405-4410.
37. Segal D. S., and, Kuczenski R., (1992) Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular dopamine responses in caudate and accumbens. Brain Res. 577, 351-355.
38. Sharp T., Zetterström T., Ljungberg T., and, Ungerstedt U., (1987) A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis. Brain Res. 401, 322-330.
39. Shimada S., Kitayama S., Walther D., and, Uhl G., (1992) Dopamine transporter mRNA: dense expression in ventral midbrain neurons. Brain Res. Mol. Brain Res. 13, 359-362.
40. Siciliano C. A., Calipari E. S., Ferris M. J., and, Jones S. R., (2014) Biphasic mechanisms of amphetamine action at the dopamine terminal. J. Neurosci., 34, 5575-5582.
41. South T., and, Huang X. F., (2008) High-fat diet exposure increases dopamine D2 receptor and decreases dopamine transporter receptor binding density in the nucleus accumbens and caudate putamen of mice. Neurochem. Res. 33, 598-605.
42. Sulzer D., (2011) How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron 69, 628-649.
43. Sulzer D., and, Rayport S., (1993) Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. Neuron 5, 797-808.
44. Sulzer D., Maidment N. T., and, Rayport S., (1990) Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J. Neurochem. 60, 527-535.
45. Wightman R. M., Amatore C., Engstrom R. C., Hale J. D., Kristensen E. W., Kuhr W. G., and, May L. J., (1998) Real-time characterization of dopamine overflow and uptake in the rat striatum. Neuroscience 25, 513-523.
46. Yeghiayan S. K., Andersen S. L., and, Baldessarini R. J., (1997) Lack of effect of chronic clorgyline or selegiline on dopamine and serotonin transporters in rat caudate-putamen or nucleus accumbens septi. Neurosci. Lett. 236, 147-150.
47. Yorgason J. T., España R. A., and, Jones S. R., (2011) Demon Voltammetry and Analysis software: analysis of cocaine-induced alterations in dopamine signaling using multiple kinetic measures. J. Neurosci. Methods 202, 158-164.
48. Zito K. A., Vickers G., and, Roberts D. C., (1985) Disruption of cocaine and heroin self-administration following kainic acid lesions of the nucleus accumbens. Pharmacol. Biochem. Behav. 23, 1029-1036.